Abstract:
Disclosed are a pharmaceutical composition for external application, an a dhesive skin patch and others which are improved in a drug release property, transdermal absorbability and stability of a pharmacologically active ingre dient contained therein and can reduce the aggravation of irritation to the skin. Specifically disclosed is an adhesive skin patch comprising a support and an adhesive layer laminated on the support, wherein the adhesive layer c ontains a pharmaceutical composition for external application. The pharmaceu tical composition for external application comprises a pharmacologically act ive ingredient, an auxiliary component and a pyrrolidone compound, wherein o ne of the pharmacologically active ingredient and the auxiliary component ha s a carboxylate group in the molecule and the other has a hydroxy group in t he molecule. Preferably, the adhesive layer further comprises a hydrogenated oil.
Abstract:
Disclosed is an adhesive skin patch having an SIS block copolymer as an a dhesive component, which has an improved handling property and can reduce ir ritation to a user. The adhesive skin patch comprises a flexible substrate a nd an adhesive layer laminated on the substrate, wherein the adhesive layer comprises a styrene-isoprene-styrene block copolymer. In the adhesive skin p atch, the tan.delta. value of the adhesive agent as determined by measuring a dynamic viscoelasticity at 32ºC satisfies a requirement represented by the following formula 1 at at least one frequency laying between 0.04 to 0.25 H z. 0.25x + 0.05
Abstract:
PROBLEM TO BE SOLVED: To provide a percutaneous absorption promotor stimulating percutaneous absorption of a drug and containing a highly safe higher fatty acid triglyceride with less irritation to the skin, and to provide a skin treatment pharmaceutical preparation and the percutaneous absorption type pharmaceutical preparation, containing the higher fatty acid glyceride. SOLUTION: This percutaneous absorption promotor contains a higher fatty acid triglyceride of 14C or more and can stimulate percutaneous absorption of a drug by application before use of a medicant drug. In addition, the skin treatment pharmaceutical preparation and the percutaneous absorption type pharmaceutical preparation are components constructing human sebum, thus are low irritant to the skin and excellent in safety. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
A skin patch that can enhance the water resistance and handling easiness and can alleviate any irritation on the user. There is provided a skin patch comprising a flexible backing and, superimposed thereon, a plaster layer wherein the plaster layer contains a styrene-isoprene-styrene block copolymer and has a glass transition temperature (Tg) of -45° to -35°C and a tan ´ (lag angle) value, determined at dynamic viscoelasticity measurement (frequency 6.2832 rad/s) at 45°C, of 0.25 or less.
Abstract:
A skin patch that can enhance the water resistance and handling easiness and can alleviate any irritation on the user. There is provided a skin patch comprising a flexible backing and, superimposed thereon, a plaster layer wherein the plaster layer contains a styrene-isoprene-styrene block copolymer and has a glass transition temperature (Tg) of -45° to -35°C and a tan ´ (lag angle) value, determined at dynamic viscoelasticity measurement (frequency 6.2832 rad/s) at 45°C, of 0.25 or less.